688317 之江生物
2025/03 - 三个月2024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)-0.447-3.416-3.41118.94128.678
总资产报酬率 ROA (%)-0.424-3.242-3.10416.89824.731
投入资产回报率 ROIC (%)-0.439-3.393-3.36818.63928.019

边际利润分析
销售毛利率 (%)64.35760.94665.12351.64562.483
营业利润率 (%)-46.464-81.536-54.49539.00544.636
息税前利润/营业总收入 (%)-77.753-155.391-88.00234.12344.281
净利润/营业总收入 (%)-49.844-71.347-49.88732.68237.573

收益指标分析
经营活动净收益/利润总额(%)123.818-12.316-7.35494.69398.460
价值变动净收益/利润总额(%)-0.998-0.0380.0000.0000.000
营业外收支净额/利润总额(%)3.1693.2584.555-0.652-0.530

偿债能力分析
流动比率 (X)21.41020.10813.3837.4638.687
速动比率 (X)21.04019.71512.3116.5017.954
资产负债率 (%)6.4064.0396.11811.45610.042
带息债务/全部投入资本 (%)3.0190.3590.4991.1841.069
股东权益/带息债务 (%)3,206.78827,694.86519,878.5148,310.0489,211.110
股东权益/负债合计 (%)1,461.1232,376.0671,534.554772.931895.781
利息保障倍数 (X)2.6122.1852.847-7.370-370.356

营运能力分析
应收账款周转天数 (天)144.150158.301216.34134.28739.719
存货周转天数 (天)424.379802.2591,425.308128.576102.473